Societal CDMO Inc
F:RAH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Banc of California Inc
NYSE:BANC
|
US |
|
NewHydrogen Inc
OTC:NEWH
|
US |
|
Hotel Royal Ltd
SGX:H12
|
SG |
|
Nexteer Automotive Group Ltd
HKEX:1316
|
US |
|
G
|
GFL Environmental Inc
NYSE:GFL
|
CA |
|
C
|
Cheniere Energy Inc
LSE:0HWH
|
US |
|
N
|
Nuenergy Holdings Bhd
KLSE:NHB
|
MY |
|
Alphabet Inc
NASDAQ:GOOGL
|
US |
|
Beaglee Inc
TSE:3981
|
JP |
Societal CDMO Inc
Total Assets
Societal CDMO Inc
Total Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Societal CDMO Inc
F:RAH
|
Total Assets
$153.5m
|
CAGR 3-Years
14%
|
CAGR 5-Years
0%
|
CAGR 10-Years
67%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Assets
$199.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Assets
$90B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
11%
|
|
|
Pfizer Inc
NYSE:PFE
|
Total Assets
$208.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Total Assets
$136.9B
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
3%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Assets
$112.5B
|
CAGR 3-Years
31%
|
CAGR 5-Years
19%
|
CAGR 10-Years
12%
|
|
Societal CDMO Inc
Glance View
Recro Pharma, Inc. is a pharmaceutical company, which engages in the contract development and manufacturing organization (CDMO). The company is headquartered in Exton, Pennsylvania and currently employs 258 full-time employees. The company went IPO on 2014-03-07. Societal CDMO is principally focused on solving various manufacturing problems. The company is a CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. In addition to its experience in handling Drug Enforcement Agency (DEA) controlled substances and developing and manufacturing modified-release dosage forms, the Company has the ability to deliver on its clients pharmaceutical development and manufacturing projects. The company conducts its operations in Gainesville, Georgia and San Diego, California.
See Also
What is Societal CDMO Inc's Total Assets?
Total Assets
153.5m
USD
Based on the financial report for Dec 31, 2023, Societal CDMO Inc's Total Assets amounts to 153.5m USD.
What is Societal CDMO Inc's Total Assets growth rate?
Total Assets CAGR 10Y
67%
Over the last year, the Total Assets growth was -2%. The average annual Total Assets growth rates for Societal CDMO Inc have been 14% over the past three years , and 67% over the past ten years .
